Pharmacogenomics - it's not just pharmacogenetics.
New technologies in both combinatorial chemistry and combinatorial biology promise to unlock new opportunities for drug discovery and lead optimisation. Using such genome-based technologies to measure the dynamic properties of pharmacological systems, pharmacogenomics can now provide an objective measure of a drug's biological efficacy, including its potential adverse effects.
Bailey
D S
DS
Pharmacogenomics Division Incyte Europe Ltd Botanic House 100 Hills Road Cambridge CB2 1FF UK. dbailey@incyte.com.
Bondar
A
A
Furness
L M
LM
D000818:Animals; D001709:Biotechnology; D004247:DNA / Q000737:chemistry / Q000235:genetics*; D019992:Databases as Topic; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D014644:Genetic Variation; D016678:Genome; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic
D004247:DNA